ArticleJCO precision oncology2026

Novel Genomic Biomarkers Improve Post-Hematopoietic Cell Transplantation Relapse Risk Stratification for Patients With Myelodysplastic Syndromes.

Tao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.